Perrigo urged to focus on its OTC businesses

15 September 2016 - Deborah Wilkes

Archived

Perrigo should focus on its "core" consumer healthcare businesses and consider divesting its "non-core" prescription pharmaceutical interests, according to investment firm Starboard Value.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: